Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Trichohyalin may trigger the immune response causing alopecia areata.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Trichohyalin in hair can trigger immune attacks in alopecia areata.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

Autoimmune hepatitis in children often affects girls and can be treated successfully with medication.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Alopecia areata involves unique activation of certain immune cells.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Patients with thyroid disorders show different symptoms and antibody levels.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Autoimmune markers may help diagnose and manage PCOS.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.